Back to Agenda
SESSION 2: International Collaboration & Regulatory Systems Strengthening
Session Chair(s)
Alia Seoud Abdalla
Global Regulatory Sciences Head (Africa Cluster) , Pfizer, Egypt
Samvel Azatyan, MD, PHD
Senior Adviser, Council For International Organizations of Medical Sciences (CIOMS), Switzerland
SESSION 2: International Collaboration & Regulatory Systems Strengthening
Speaker(s)
Dalia Abou Hussein
Quality Assurance (QA) General Director, Egyptian Drug Authority (EDA), Egypt
Strengthening Regulatory Systems, EDA’s Milestone towards WHO GBT Maturity Level 3
Bandar Al Hammad, MPHARM
Chief Pharmacist & Director of Veterinary Products Department, Saudi Food and Drug Authority (SFDA), Saudi Arabia
Saudi FDA’s ML4 & WLA Journey
Sonia Sebai Ben Amor
Head - National Control Laboratory National Regulatory Authority, Tunisian Medicines Agency (AEMPS), Tunisia
Tunisia’s experience with Reliance and role in North Africa Harmonisation initiative
Nancy Yang Ngum
Public Health Officer (Public Health Expert), African Union Development Agency (AUDA-NEPAD), South Africa
Convergence and Harmonisation in Africa: AMA operationalisation progress, AMA continental pilot, Africa Continental Reliance Framework and North Africa Harmonisation initiative
Christine Ledimo
Senior Director: Regulatory Affcairs SSA, MSD , South Africa
Reliance Pilots - Industry experience with AMA continental pilot
Charlene Roopnarain
Regulatory Affairs Cluster Head - South Africa, Nigeria and East Africa, Merck Serono, South Africa
Reliance Pilots - Industry experience with AMA continental pilot
Enas Hijjih
Head of Bioequivalence Division- Registration department, Jordan Food and Drug Administration (JFDA), Jordan
Panel Discussion with Q&A (With the additional participation of):
Have an account?